Study S002206

A Clinical Study of Mass Balance of [14C]HRS-7535 in Healthy Adult Chinese Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06819488
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 6
Start: 2025-02-27
Primary completion: 2025-04-16
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Type 2 Diabetes Mellitus; Weight Loss
Interventions: DRUG:[14C]HRS-7535
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

The time of maximum observed concentration (Tmax) [0-120 hours.]
The maximum observed concentration (Cmax) [0-120 hours.]
The terminal half-life (t1/2) [0-120 hours.]
The total body clearance for extravascular administration (CL/F) [0-120 hours.]
The total radioactivity ratio for blood [0-96 hours.]
The total radioactivity ratio for plasma [0-96 hours.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.